S1828 Predictors of Response to Ustekinumab and Identification of Factors Associated With Dose Escalation in Patients With Inflammatory Bowel Disease
Jordan E. Axelrad(New York University), Raymond K. Cross(University of Maryland, Baltimore), Chelsea Anderson(University of North Carolina at Chapel Hill), Millie D. Long(University of North Carolina Health Care), Dania Hudhud, Angela Ruohao Wu(Hong Kong University of Science and Technology), Vishal Chaudhary, Sara Horst(Vanderbilt University Medical Center), Ellen Axenfeld, Audrey Bennett
Cited by 0
Related Papers
ACG Clinical Guideline: Ulcerative Colitis in Adults
|The American Journal of Gastroenterology|2019|1.6k
Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm
|Journal of Addiction Medicine|2017|177
Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease
|Gastroenterology|2016|162
Acute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior
|Molecular Psychiatry|2016|97